Partnerships: NIA/NIH/FDA collaboration (Milestone 14.O)
In Progress
Timeline Start - End
2024 - 2025Research Implementation Area
Public Private PartnershipsEnable close collaboration between NIH and FDA to advance biomarkers and therapy development for AD/ADRD.
Success Criteria
- Convene joint workshops, public symposia, and establish MOUs to promote a close collaboration between NIH and FDA for the advancement of biomarker and therapy development for AD/ADRD.
Summary of Key Accomplishments
This milestone has yet to be initiated. Accomplishments are forthcoming.
The key accomplishments summary is current as of July 2022.